Gracell Biotechnologies Inc. — Operating Income by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b5b1837d-41d6-4769-b40b-20b0958e13db/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2022 | $-90.6M | 2022-01-01 – 2022-12-31 | evidence 0001104659-23-049599 |
| FY 2021 | $-72.7M | 2021-01-01 – 2021-12-31 | evidence 0001193125-22-115083 |
| FY 2020 | $-32.9M | 2020-01-01 – 2020-12-31 | evidence 0001193125-21-128979 |
| FY 2019 | — | 2019-01-01 – 2019-12-31 | evidence 0001193125-21-128979 |
| FY 2018 | — | 2018-01-01 – 2018-12-31 | evidence 0001193125-21-128979 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).